Search results
What to know about Bell's palsy, the facial paralysis affecting Joel Embiid
ABC News· 22 hours agoBell’s palsy occurs when something inflames or injures a nerve that controls facial muscles. It can...
The Best Foods To Eat To Keep Your Blood Sugar Stable All Day
Women s Health· 23 hours agoGetting a type 2 diabetes diagnosis can feel overwhelming, and it may seem difficult to nail down...
Microscopic Colitis
Health via Yahoo News· 2 days agoIt is most common in older adults and people with autoimmune disorders like celiac disease. There is no cure for microscopic colitis, but most people can...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 2 days agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
Scientists discover potential biomarkers of environmental exposures in Parkinson's disease
Medical Xpress· 24 hours agoThe study, led by Paulina... Davee Department of Neurology's Division of Movement Disorders, demonstrates the potential of utilizing DNA methylation as a biomarker and diagnostic ...
$2.7 million grant to explore hypoxia’s impact on blood stem cells
Newswise· 1 day agoA new four-year, $2.7 million grant from the National Institute of Diabetes and Digestive and Kidney...
Tennessee regulations prevent good addiction treatment for opioid use disorder patients
The Tennessean via Yahoo News· 1 day agoThese things are not happening to people with high blood pressure or diabetes, but Tennessee does...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 1 day agoThe treatment, called Beqvez, gained clearance for patients with hemophilia B, a rare bleeding disorder, Pfizer said Friday in a statement. Pfizer’s medicine is a one-time ...
Missy Elliott Nearly Got Into A Car Crash Amid Graves' Disease Tremors
Women's Health via Yahoo News· 21 hours agoIn 2008, Missy Elliott was diagnosed with Graves' disease. Here's everything to know about her...
Sanofi wins in late-stage trial for blood disorder candidate (NASDAQ:SNY)
Seeking Alpha· 4 days agoSanofi's (SNY) oral therapy, rilzabrutinib, shows promise in a Phase 3 trial for an autoimmune blood...
